Single answer

Is Adlai Nortye Ltd (ANL) a buy or sell?

4starter turns market data into one clear verdict you can act on.

Hold
$1.420
-0.0700 (-4.70%)
Quote updated: 2025-12-31 21:00 UTC
Trend today
-4.70%
Down today
Volume vs avg
Not available
Target gap
533.80%
above current price
Signal updated
Not available
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Add to watchlist

Create a free account to save tickers and track your signals.

Log in to turn on watchlist alerts.

What is the conclusion?

Right now our advanced algorithms say:

YES

Do analysts agree?

We compare consensus targets with today's price.

YES

Consensus target for Adlai Nortye Ltd is $9.00, which is $7.58 (533.80%) above the current price today's price.

Low target: $9.00 | High target: $9.00

Company snapshot

A quick overview of the business and its public profile.

Adlai Nortye Ltd a clinicalstage biotechnology company engages in the research and development of pharmaceutical products Its lead product is AN2025 a panphosphoinositide 3kinase inhibitor which is in Phase III clinical trials for the treatment of recurrent or metastatic head and neck squamous cell carcinomas The company is also developing AN0025 a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent nonsmall cell lung cancer and urothelial cancer after antiPD1PDL1 treatments recurrent triplenegative breast cancer microsatellite stable colorectal cancer and cervical cancer after standard of care treatments and AN4005 an oral smallmolecule PDL1 inhibitor which is in Phase I clinical trials to induce and stabilize PDL1 dimerization and disrupt the interaction between PD1 and PDL1 Its preclinical candidates include AN8025 a multifunctional antibody as T cell and antigenpresenting cell modulator and AN9025 an oral small molecule panKRAS inhibitor The company was founded in 2004 and is based in Grand Cayman the Cayman Islands

Website: https://www.adlainortye.com

Rates and inflation backdrop

US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.

Inflation sensitivity

Debt ratio: 0.38. Cash flow to debt ratio: -1.90. Net profit margin: 0.00%. Inflation risk score: high (0.75/1).

Dividend history check

We cannot find any recorded dividends paid in our systems.

Trading liquidity

No, the average daily trading liquidity for Adlai Nortye Ltd is $456,724. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

10-year return check

We cannot find data for Adlai Nortye Ltd 10 years ago, but if you had invested on 2023-09-28 when the price was $0.0000, you would have made a profit of $1.490 per share or 14,899,900.00%.

Why this answer

We combine price momentum, volatility, and trend signals to simplify the decision to one word.

1

Signal engine scans price, trend, and momentum indicators.

2

Targets and sentiment are checked against the live quote.

3

We keep the output simple: buy, sell, or hold.

Analyst consensus

How Wall Street targets compare to today's price.

$9.00
$7.58 (533.80%) above the current price
Range: $9.00 - $9.00

FAQ

Today's 4starter signal is Hold. That means the signal is mixed right now.

Quotes and targets refresh throughout the trading day, with the latest timestamp shown on the page.

It blends momentum, trend, and volatility indicators into a single decision-oriented verdict.